DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Tom Bschor - 1 Jonathan Alpert - 1 Dorothy - 1 Marty Silverman - 1 Alpert - 1 wasn’t - 1 Bschor - 1 ” Bschor - 1
Top related locs:
Germany New York City North Carolina Brazil’s Federal University of Santa Maria NewYork Chicago , Illinois U.S New York
Top related orgs:
CNN - 1 Psychiatry - 1 University Hospital Dresden - 1 Albert Einstein College of Medicine - 1 Duke University Medical Center - 1 Brazil’s Federal University of Santa - 1 The New York Times - 1 Duke University Medical - 1

Search resuls for: "Duke University Medical"


4 mentions found


☆ Placebos can improve mental health symptoms, study finds
  + stars: | 2024-05-29 | by ( Kristen Rogers | ) edition.cnn.com   time to read: +7 min
CNN —When you’re trying to address mental health symptoms, simply the belief that you can be helped may be an important factor. Symptoms of nine mental health disorders substantially improved under placebo treatment, according to a new review of 90 randomized controlled trials — known as a meta-analysis — totaling 9,985 adult participants largely in their 30s and 40s. “This is the most comprehensive study of placebo effects in psychiatry.”The results are also important for patient treatment, Bschor said. But for disorders that didn’t see as much improvement with placebos — such as OCD or schizophrenia, which is a psychotic disorder — medication may be more necessary. Improvement in absence of medicationThat mental health symptoms improved with placebo treatment may be due to a few potential influences, experts said.
Persons: Tom Bschor, Jonathan Alpert, Dorothy, Marty Silverman, Alpert, wasn’t, Bschor, ” Bschor, ”, Richard Keefe, Keefe, Felipe Barreto Schuch, ” Schuch wasn’t, “, ” Alpert, you’ve Organizations: CNN, Psychiatry, University Hospital Dresden, Albert Einstein College of Medicine, Duke University Medical Center, Brazil’s Federal University of Santa Locations: Germany, New York City, North Carolina, Brazil’s Federal University of Santa Maria
☆ R.F.K. Jr. Says Doctors Found a Dead Worm in His Brain
  + stars: | 2024-05-08 | by ( Susanne Craig | ) www.nytimes.com   time to read: +1 min
In 2010, Robert F. Kennedy Jr. was experiencing memory loss and mental fogginess so severe that a friend grew concerned he might have a brain tumor. Several doctors noticed a dark spot on the younger Mr. Kennedy’s brain scans and concluded that he had a tumor, he said in a 2012 deposition reviewed by The New York Times. Mr. Kennedy was immediately scheduled for a procedure at Duke University Medical Center by the same surgeon who had operated on his uncle, he said. While packing for the trip, he said, he received a call from a doctor at NewYork-Presbyterian Hospital who had a different opinion: Mr. Kennedy, he believed, had a dead parasite in his head. The doctor believed that the abnormality seen on his scans “was caused by a worm that got into my brain and ate a portion of it and then died,” Mr. Kennedy said in the deposition.
Persons: Robert F, Kennedy Jr, Kennedy, Edward M, ” Mr Organizations: The New York Times, Duke University Medical, Presbyterian Hospital Locations: NewYork
☆ Obesity drug Wegovy's popularity has US employers rethinking insurance coverage
  + stars: | 2023-06-27 | by ( Patrick Wingrove | ) www.reuters.com   time to read: +6 min
[1/2] A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. A new and more expensive version of the drug specifically for weight loss, called Wegovy, had been approved in 2021 by U.S. health regulators. Employers that cover weight-loss drugs have required medical practices to document patients’ need for Wegovy since it was approved. The federal Medicare healthcare program for Americans aged 65 and older cannot cover weight loss treatments by law. Only 16 states – the most populous being California, Pennsylvania and Michigan – cover Wegovy and other obesity drugs under their Medicaid plans for low-income patients.
Persons: Jim Vondruska, Shawnte, Aon, Mercer, Willis Towers Watson, Eli Lilly, Jeff Levin, Levin, Scherz, Michael Manolakis, William Yancy, Manolakis, Patrick Wingrove, Michele Gershberg, Suzanne Goldenberg Organizations: REUTERS, New, Warner Bros, Warner Bros Discovery Inc, Reuters, Marsh & McLennan, Employers, Barclays Research, Novo Nordisk, Duke University, Thomson Locations: Chicago , Illinois, U.S, New York, Marsh, Wegovy, California, Pennsylvania, Michigan
☆ Cognitive decline, dementia common after stroke
  + stars: | 2023-05-01 | by ( Sandee Lamotte | ) edition.cnn.com   time to read: +6 min
About 40% of the survivors of stroke have mild cognitive impairment that does not meet the diagnostic criteria for dementia. Cognitive impairment is most common within the first two weeks after a stroke, the statement said. The American Stroke Association’s statement did offer some good news: About 20% of people who experience mild cognitive impairment after a stroke fully recover their cognitive function, typically within the first six months. Stroke risk factors, such as hypertension, high cholesterol and type 2 diabetes, should be treated, as should atrial fibrillation. “Perhaps the most pressing need, however, is the development of effective and culturally relevant treatments for post-stroke cognitive impairment,” she said.
0 next >>
Total: 4